Kangmei Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Kangmei Pharmaceutical has a total shareholder equity of CN¥7.1B and total debt of CN¥30.0M, which brings its debt-to-equity ratio to 0.4%. Its total assets and total liabilities are CN¥14.2B and CN¥7.1B respectively. Kangmei Pharmaceutical's EBIT is CN¥240.0M making its interest coverage ratio -6.2. It has cash and short-term investments of CN¥744.8M.
Key information
0.4%
Debt to equity ratio
CN¥29.96m
Debt
| Interest coverage ratio | -6.2x |
| Cash | CN¥744.76m |
| Equity | CN¥7.09b |
| Total liabilities | CN¥7.12b |
| Total assets | CN¥14.21b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 600518's short term assets (CN¥6.9B) exceed its short term liabilities (CN¥4.6B).
Long Term Liabilities: 600518's short term assets (CN¥6.9B) exceed its long term liabilities (CN¥2.5B).
Debt to Equity History and Analysis
Debt Level: 600518 has more cash than its total debt.
Reducing Debt: 600518's debt to equity ratio has reduced from 123.3% to 0.4% over the past 5 years.
Debt Coverage: 600518's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: 600518 earns more interest than it pays, so coverage of interest payments is not a concern.